|
1
|
Liao CC, Lin CS, Shih CC, Yeh CC, Chang
YC, Lee YW and Chen TL: Increased risk of fracture and postfracture
adverse events in patients with diabetes: Two nationwide
population-based retrospective cohort studies. Diabetes Care.
37:2246–2252. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
American Diabetes Association Professional
Practice Committee. 4. Comprehensive medical evaluation and
assessment of comorbidities: Standards of care in diabetes-2024.
Diabetes Care. 47 (Suppl 1):S52–S76. 2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Starup-Linde J, Hygum K, Harslof T and
Langdahl B: Type 1 diabetes and bone fragility: Links and risks.
Diabetes Metab Syndr Obes. 12:2539–2547. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Carnevale V, Romagnoli E and D'Erasmo E:
Skeletal involvement in patients with diabetes mellitus. Diabetes
Metab Res Rev. 20:196–204. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Hygum K, Starup-Linde J, Harslof T,
Vestergaard P and Langdahl BL: MECHANISMS IN ENDOCRINOLOGY:
Diabetes mellitus, a state of low bone turnover-a systematic review
and meta-analysis. Eur J Endocrinol. 176:R137–R157. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Starup-Linde J, Lykkeboe S, Gregersen S,
Hauge EM, Langdahl BL, Handberg A and Vestergaard P: Bone structure
and predictors of fracture in type 1 and type 2 diabetes. J Clin
Endocrinol Metab. 101:928–936. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kanazawa I and Sugimoto T: Diabetes
Mellitus-induced bone fragility. Intern Med. 57:2773–2785.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sheu A, White CP and Center JR: Bone
metabolism in diabetes: A Clinician's guide to understanding the
bone-glucose interplay. Diabetologia. 67:1493–1506. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Koh G, Suh KS, Chon S, Oh S, Woo JT, Kim
SW, Kim JW and Kim YS: Elevated cAMP level attenuates
2-deoxy-d-ribose-induced oxidative damage in pancreatic beta-cells.
Arch Biochem Biophys. 438:70–79. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kim HS, Suh KS, Ko A, Sul D, Choi D, Lee
SK and Jung WW: The flavonoid glabridin attenuates
2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction
in MC3T3-E1 osteoblastic cells. Int J Mol Med. 31:243–251.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ferreira JP, Verdonschot J, Wang P, Pizard
A, Collier T, Ahmed FZ, Brunner-La-Rocca HP, Clark AL, Cosmi F,
Cuthbert J, et al: Proteomic and mechanistic analysis of
spironolactone in patients at risk for HF. JACC Heart Fail.
9:268–277. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Park SY, Suh KS, Jung WW and Chin SO:
Spironolactone attenuates methylglyoxal-induced cellular
dysfunction in MC3T3-E1 osteoblastic cells. J Korean Med Sci.
36(e265)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Suh KS, Chon S and Choi EM: Protective
effects of piceatannol on methylglyoxal-induced cytotoxicity in
MC3T3-E1 osteoblastic cells. Free Radic Res. 52:712–723.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Piazena H and Kelleher D: Comments on
‘Cellular response to infrared radiation involves retrograde
mitochondrial signaling’. Free Radic Biol Med. 44:1869–1871.
2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Suh KS, Choi EM, Kwon M, Chon S, Oh S, Woo
JT, Kim SW, Kim JW and Kim YS: Kaempferol attenuates
2-deoxy-d-ribose-induced oxidative cell damage in MC3T3-E1
osteoblastic cells. Biol Pharm Bull. 32:746–749. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rhee SG: Cell signaling. H2O2, a necessary
evil for cell signaling. Science. 312:1882–1883. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jacobson MD: Reactive oxygen species and
programmed cell death. Trends Biochem Sci. 21:83–86.
1996.PubMed/NCBI
|
|
19
|
Ellgaard L and Helenius A: Quality control
in the endoplasmic reticulum. Nat Rev Mol Cell Biol. 4:181–191.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Mei Y, Thompson MD, Cohen RA and Tong X:
Endoplasmic reticulum stress and related pathological processes. J
Pharmacol Biomed Anal. 1(1000107)2013.PubMed/NCBI
|
|
21
|
Schroder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789.
2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Bhatti JS, Bhatti GK and Reddy PH:
Mitochondrial dysfunction and oxidative stress in metabolic
disorders-A step towards mitochondria based therapeutic strategies.
Biochim Biophys Acta Mol Basis Dis. 1863:1066–1077. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mittal M, Siddiqui MR, Tran K, Reddy SP
and Malik AB: Reactive oxygen species in inflammation and tissue
injury. Antioxid Redox Signal. 20:1126–1167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hansen PR, Rieneck K and Bendtzen K:
Spironolactone inhibits production of proinflammatory cytokines by
human mononuclear cells. Immunol Lett. 91:87–91. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu W, Gong W, He M, Liu Y, Yang Y, Wang
M, Wu M, Guo S, Yu Y, Wang X, et al: Spironolactone protects
against diabetic cardiomyopathy in streptozotocin-induced diabetic
rats. J Diabetes Res. 2018(9232065)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Mayyas F, Alzoubi KH and Bonyan R: The
role of spironolactone on myocardial oxidative stress in rat model
of streptozotocin-induced diabetes. Cardiovasc Ther.
35(e12242)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang CC, Lee AS, Liu SH, Chang KC, Shen MY
and Chang CT: Spironolactone ameliorates endothelial dysfunction
through inhibition of the AGE/RAGE axis in a chronic renal failure
rat model. BMC Nephrol. 20(351)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Do MH, Hur J, Choi J, Kim M, Kim MJ, Kim Y
and Ha SK: Eucommia ulmoides ameliorates glucotoxicity by
suppressing advanced glycation end-products in diabetic mice
kidney. Nutrients. 10(265)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chhokar VS, Sun Y, Bhattacharya SK, Ahokas
RA, Myers LK, Xing Z, Smith RA, Gerling IC and Weber KT: Loss of
bone minerals and strength in rats with aldosteronism. Am J Physiol
Heart Circ Physiol. 287:H2023–H2026. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Carbone LD, Cross JD, Raza SH, Bush AJ,
Sepanski RJ, Dhawan S, Khan BQ, Gupta M, Ahmad K, Khouzam RN, et
al: Fracture risk in men with congestive heart failure risk
reduction with spironolactone. J Am Coll Cardiol. 52:135–138.
2008.PubMed/NCBI View Article : Google Scholar
|
